AirSculpt Technologies, Inc. Net Income (Loss) Available to Common Stockholders, Basic
AirSculpt Technologies, Inc. (AIRS) reported Net Income (Loss) Available to Common Stockholders, Basic of -$1.11 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-10
- AirSculpt Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$1.11M.
- AirSculpt Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$2.40M.
- AirSculpt Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was $1.28M.
- AirSculpt Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$9.51M.
- AirSculpt Technologies, Inc. net income (loss) available to common stockholders, basic for fiscal 2025 was -$11.67M.
- AirSculpt Technologies, Inc. net income (loss) available to common stockholders, basic for fiscal 2024 was -$8.02M.
- AirSculpt Technologies, Inc. net income (loss) available to common stockholders, basic for fiscal 2023 was -$4.24M.
- AirSculpt Technologies, Inc. net income (loss) available to common stockholders, basic for fiscal 2022 was -$14.68M, a 239.12% decline from fiscal 2021.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$1.11M 10-Q · filed 2026-08-10 | -$3.51M 10-Q · filed 2026-08-10 | -$2.23M derived: sum of 3 quarters · filed 2026-08-10 | -$11.74M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | -$2.40M 10-Q · filed 2026-05-08 | -$1.11M derived: sum of 2 quarters · filed 2026-05-08 | -$10.63M derived: sum of 3 quarters · filed 2026-05-08 | -$11.22M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | $1.28M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | -$8.23M derived: sum of 2 quarters · filed 2026-04-06 | -$8.82M derived: sum of 3 quarters · filed 2026-08-10 | -$11.67M 10-K/A · filed 2026-04-06 | |
| 2025-09-30 | -$9.51M 10-Q · filed 2025-11-07 | -$10.10M derived: sum of 2 quarters · filed 2026-08-10 | -$12.95M 10-Q · filed 2025-11-07 | -$17.75M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | -$591.00K 10-Q · filed 2026-08-10 | -$3.44M 10-Q · filed 2026-08-10 | -$8.24M derived: sum of 3 quarters · filed 2026-08-10 | -$14.28M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | -$2.85M 10-Q · filed 2026-05-08 | -$7.65M derived: sum of 2 quarters · filed 2026-05-08 | -$13.69M derived: sum of 3 quarters · filed 2026-05-08 | -$16.89M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$4.80M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | -$10.84M derived: sum of 2 quarters · filed 2026-04-06 | -$14.05M derived: sum of 3 quarters · filed 2026-04-06 | -$8.02M 10-K/A · filed 2026-04-06 | -$8.25M 10-K · filed 2025-03-14 |
| 2024-09-30 | -$6.04M 10-Q · filed 2025-11-07 | -$9.25M derived: sum of 2 quarters · filed 2025-11-07 | -$3.22M 10-Q · filed 2025-11-07 | -$7.55M derived: sum of 4 quarters · filed 2026-04-06 | |
| 2024-06-30 | -$3.21M 10-Q · filed 2025-08-01 | $2.82M 10-Q · filed 2025-08-01 | -$1.51M derived: sum of 3 quarters · filed 2026-04-06 | -$3.18M derived: sum of 4 quarters · filed 2026-04-06 | |
| 2024-03-31 | $6.03M 10-Q · filed 2025-05-02 | $1.69M derived: sum of 2 quarters · filed 2026-04-06 | $27.00K derived: sum of 3 quarters · filed 2026-04-06 | $1.80M derived: sum of 4 quarters · filed 2026-04-06 | |
| 2023-12-31 | -$4.33M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | -$6.00M derived: sum of 2 quarters · filed 2026-04-06 | -$4.23M derived: sum of 3 quarters · filed 2026-04-06 | -$4.24M 10-K/A · filed 2026-04-06 | -$4.48M 10-K · filed 2024-02-27 |
| 2023-09-30 | -$1.67M 10-Q · filed 2023-11-13 | $109.00K derived: sum of 2 quarters · filed 2023-11-13 | $95.00K 10-Q · filed 2023-11-13 | -$7.10M derived: sum of 4 quarters · filed 2025-03-14 | |
| 2023-06-30 | $1.78M 10-Q · filed 2023-08-11 | $1.76M 10-Q · filed 2023-08-11 | -$5.43M derived: sum of 3 quarters · filed 2025-03-14 | -$12.81M derived: sum of 4 quarters · filed 2025-03-14 | |
| 2023-03-31 | -$14.00K 10-Q · filed 2023-05-12 | -$7.21M derived: sum of 2 quarters · filed 2025-03-14 | -$14.58M derived: sum of 3 quarters · filed 2025-03-14 | -$14.00M derived: sum of 4 quarters · filed 2025-03-14 | |
| 2022-12-31 | -$7.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$14.57M derived: sum of 2 quarters · filed 2025-03-14 | -$13.99M derived: sum of 3 quarters · filed 2025-03-14 | -$14.68M 10-K · filed 2025-03-14 | |
| 2022-09-30 | -$7.38M 10-Q · filed 2023-11-13 | -$6.79M derived: sum of 2 quarters · filed 2023-11-13 | -$7.49M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $583.00K 10-Q · filed 2023-08-11 | -$110.00K 10-Q · filed 2023-08-11 | |||
| 2022-03-31 | -$693.00K 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | $10.55M 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |